On the FDA’s docket this month are two expansion bids, one for GSK’s asthma drug Nucala into COPD and another for Merck’s ...

with more than three-quarters of individuals already having moderate or severe/very severe airflow obstruction at the time of diagnosis 6. The small airways, often referred to as the silent zone ...

techniques to simulate airflow through the airway and pinpoint areas of turbulence, which are key indicators of obstruction. These combined techniques allowed the researchers to accurately ...

Evidence of airflow obstruction (based on FEV/VC <LLN) was observed in 54 (17%) of athletes, 11 (20%) of whom had a supra-normal FVC values. When these athletes were excluded, the group median FEV1 ...